Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Waitara
Clinical trial register · Australia

Clinical Trials in Waitara, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Australia and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 3348 matching records held by the registry are in this view. Synced 18 Oct 2026, 03:18 UTC
3348
Studies in scope
all four open statuses
1802
Recruiting now
open to new participants
765
Lead sponsors
across recruiting studies
Top sites
Melbourne 1099 Adelaide 566 Sydney 511 Westmead 417 Clayton 408
Narrow the registerReset
Recruitment status
Phase
Site location
Melbourne1099 Adelaide566 Sydney511 Westmead417 Clayton408
All 399 locations
Target enrolment
to

Trials with a site in Waitara

10 of 3348 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Australia
Start
Not yet open
Hemay Pharmaceutical PTY. LTD.
Phase 2
90
Waitara
2026-11-01
Recruiting
Novartis Pharmaceuticals
Phase 2
259
Sydney, Waitara, Melbourne
2026-09-29
Recruiting
AstraZeneca
Phase 3
1,500
Botany, Camberwell, Charlestown, Helensvale, Maroubra, Waitara
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Botany, Kotara, Malvern, St Albans, St Leonards, Waitara
2026-08-19
Recruiting
HB BioTech, LLC
Phase 2
200
Deakin, Charlestown, Darlinghurst, Waitara, Westmead, Herston, Mackay, Morayfield
2026-06-03
Recruiting
Novartis Pharmaceuticals
Phase 2
210
Sydney, Waitara, Melbourne
2026-03-09
Recruiting
Phase 2 Randomized Double-blind Study to Assess Topical Zabalafin Hydrogel Vs Vehicle in Mild to Moderate AD.
NCT06855745Atopic Dermatitis (Eczema), Atopic Dermatitis Eczema, Atopic Dermatitis, Atopic Dermatitis (AD)
Alphyn Biologics
Phase 2
72
Brookvale, Darlinghurst, Kogarah, Kotara, Waitara, Wollongong, Benowa, Wellers Hill
2025-03-25
Recruiting
Feldan Therapeutics
Phase 1
48
Phillip, Charlestown, Randwick, Waitara, Westcourt, Woolloongabba
2024-10-30
Active, closed
Dynavax Technologies Corporation
Phase 1/2
764
Blacktown, Botany, Brookvale, Kanwal, Miranda, Waitara, Wollongong, Herston
2024-06-17
Recruiting
Sanofi Pasteur, a Sanofi Company
Phase 1/2
800
Phillip, Kotara, Sydney, Waitara, Woolloongabba, Carlton, Melbourne
2024-04-05
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Australian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 18 October 2026. https://priyalifescience.com/clinical-trials-australia/city/waitara

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Australia and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 3,348 studies in total at the last sync on 18 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Waitara.

How many clinical trials are recruiting in Waitara?

8 of the 10 studies on this page are recruiting new participants as of the 18 Oct 2026, 03:18 UTC sync. A further 1 have not yet opened recruitment, 1 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Waitara), 10 studies
PhaseStudiesRecruitingShare
Phase 25450%
Phase 1/22120%
Phase 32220%
Phase 11110%

Most active sponsors

Lead sponsors with the most studies (Waitara)
Lead sponsorStudiesRecruiting
AstraZeneca22
Novartis Pharmaceuticals22
Alphyn Biologics11
Dynavax Technologies Corporation10
Feldan Therapeutics11
HB BioTech, LLC11
Hemay Pharmaceutical PTY. LTD.10
Sanofi Pasteur, a Sanofi Company11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.